Back

SGLT2 inhibitors across the spectrum of heart failure - discussion.

21 May 2022 (14:33 - 14:45)
Organised by:
Congress Presentation Part of: SGLT2 inhibitors across the spectrum of heart failure Chronic Heart Failure HFA Premium Access Heart Failure 2022

4 More presentations in this session

Presentation thumbnail
Decoding cardio-protection with SGLT2 inhibitors: new insights into cardio-renal mechanisms.
Professor P. Seferovic (Belgrade, RS)
Slides Video
Presentation thumbnail
SGLT2 inhibitors: major cardiovascular outcomes in ambulatory patients with HFrEF.
Professor G. Rosano (London, GB)
Slides Video
Presentation thumbnail
SGLT2 inhibitors in worsening and decompensated heart failure: a promising perspective.
Professor P. Ponikowski (Wroclaw, PL)
Slides Video
Presentation thumbnail
SGLT2 inhibitors in HFmrEF and HFpEF: fulfilling an unmet need?
Professor M. Petrie (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
SGLT2 inhibitors across the spectrum of heart failure
Video

The Event

Event poster

Heart Failure 2022

21 May 2022 14:33 CET
You may be interested in
thumbnail
Congress Presentation
Updates on current heart failure treatment - discussion
13 May 2024
thumbnail
Congress Presentation
An algorithm for treatment of HFpEF and obesity: SGLT2i? GLP-1RA? or both?
13 May 2024
thumbnail
Congress Presentation
Management of obesity across the stages of heart failure - discussion
13 May 2024
thumbnail
Congress Presentation
Discussion.
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources